OTC Healthcare in Peru
Euromonitor International's OTC Healthcare in Peru market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 86 | Publication date: Feb 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Economic growth raises demand for medicines
The strong performance of the Peruvian economy in 2008 impacted overall pharmaceuticals: Peruvians had increased disposable income that led to greater expenditure. Specifically, OTC experienced increased demand for medicines from three sources. High-income to medium-income consumers increased demand for a greater number of brand medicines; low-income consumers accessed OTC products for the first time, and the Government increased its overall medication purchases to meet the expanding requirements of public hospitals.
Free trade agreements expected to alter regulation of pharmaceutical products
In the context of the implementation of the Free Trade Agreement (FTA) between the US and Peru, in June 2008 the Peruvian Government approved the Legislative Decree No 1072. This stated that ‘test data’ (Datos de Prueba) would be protected ‘generally’ for five years. Test data is the information developed to guarantee the security of the consumer and the effectiveness of the medical product, based on clinical tests on patients. As the law does not indicate a maximum limit of time for the protection, the measure could cause much delay in the access to new generic medicaments. In addition to this, a Free Trade Agreement between China and Peru is currently being negotiated. This has raised concerns regarding the unfair competition that domestic pharmaceuticals would encounter, since the price of Chinese medicine is remarkably cheaper due to lower costs in production.
Domestic laboratories increase market share
Domestic laboratories took advantage of the higher demand for medicines from both private consumers and the government in meeting public health requirements. The main initiatives carried out by domestic laboratories included the expansion of their installed capacity, the offer of new products, and improvements in marketing strategies. During the review period, domestic laboratories benefited most from the improving economic situation, due to the fact that they experienced an increase in sales of natural and herbal-based products.
Drugstores hold commanding share of OTC healthcare
Parapharmacies/drugstores dominated the distribution of OTC healthcare in Peru in 2008, and increased its share in most categories. The largest chained drugstores, such as Inkafarma, Boticas BTL and Boticas Fasa, chose to expand through new stores, both in Lima and in other provinces. Meanwhile, Mifarma – a smaller chained drugstore – increased considerably its number of clients through improved quality of service, free delivery service without a minimum value sale, and free periodical medical check-ups inside its stores. Progressively, pharmacies decreased in Peru’s capital, although it maintained its presence in provinces outside Lima.
Natural/traditional products to increase in demand
Natural herbal/traditional products are expected to experience increased demand over the forecast period. Peruvian consumers are gaining knowledge about the healing properties of these products. In addition, the availability of natural herbal/traditional products has increased, not only in healthfood shops but also in drugstores and supermarkets/hypermarkets. It is also notable that Peruvian consumers are willing to consume herbal/traditional products, as they feel proud that these natural remedies are often domestically derived and culturally accepted in the healing of different types of ailments. As a result, several traditional plants/herbs, such as maca, yacón, and noni, have gained a very strong reputation for their medicinal use.
Table of contents
OTC HEALTHCARE IN PERU : MARKET INSIGHT
EXECUTIVE SUMMARY
Economic growth raises demand for medicines
Free trade agreements expected to alter regulation of pharmaceutical products
Domestic laboratories increase market share
Drugstores hold commanding share of OTC healthcare
Natural/traditional products to increase in demand
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Penetration of Private Label by Sector 2003-2008
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
De-Listing or De-Reimbursement
Advertising
Packaging
Labelling
Pharmaceutical Registration
Patent Protection and Intellectual Property Rights
Distribution
Primary OTC Product Distributors
Pharmacies, drugstores and chains
Summary 1 OTC Distributors and Major Retailers – Peru
Vitamins and Dietary Supplements Registration and Classification
Generics
Switches
DEFINITIONS
Government Organisations
Trade Associations
Summary 2 Research Sources
ANALGESICS IN PERU
Headlines
Trends
switches
Competitive Landscape
Prospects
Sector Data
Table 12 Sales of Analgesics by Subsector: Value 2003-2008
Table 13 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 14 Herbal vs Standard Topical Analgesics 2003-2008
Table 15 Analgesics Company Shares by Value 2004-2008
Table 16 Analgesics Brand Shares by Value 2005-2008
Table 17 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 18 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN PERU
Headlines
Trends
switches
Competitive Landscape
Prospects
Sector Data
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
Table 21 Sales of Decongestants by Type: Value 2003-2008
Table 22 Sales of Decongestants by Type: % Value Growth 2003-2008
Table 23 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
Table 25 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
Table 26 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
Table 27 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013
DIGESTIVE REMEDIES IN PERU
HeadlineS
Trends
switches
Competitive Landscape
Prospects
Sector Data
Table 30 Sales of Digestive Remedies by Subsector: Value 2003-2008
Table 31 Sales of Digestive Remedies by Subsector: % Value Growth 2003-2008
Table 32 Herbal vs Standard Digestive Remedies 2003-2008
Table 33 Digestive Remedies Company Shares by Value 2004-2008
Table 34 Digestive Remedies Brand Shares by Value 2005-2008
Table 35 Forecast Sales of Digestive Remedies by Subsector: Value 2008-2013
Table 36 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2008-2013
MEDICATED SKIN CARE IN PERU
Headlines
Trends
switches
Competitive Landscape
Prospects
Sector Data
Table 37 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 38 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 39 Herbal vs Standard Medicated Skin Care 2003-2008
Table 40 Medicated Skin Care Company Shares by Value 2004-2008
Table 41 Medicated Skin Care Brand Shares by Value 2005-2008
Table 42 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 43 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 44 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
VITAMINS AND DIETARY SUPPLEMENTS IN PERU
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
Table 45 Sales of Vitamins and Dietary Supplements by Subsector: Value 2003-2008
Table 46 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
Table 47 Vitamins and Dietary Supplements Company Shares by Value 2004-2008
Table 48 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
Table 49 Vitamins Brand Shares by Value 2005-2008
Table 50 Dietary Supplements Brand Shares by Value 2005-2008
Table 51 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2008-2013
Table 52 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013
NRT SMOKING CESSATION AIDS IN PERU
Headlines
Sector Indicators
Table 53 Number of Smokers by Gender 2003-2008
EYE CARE IN PERU
Headlines
Sector Data
Table 54 Sales of Eye Care by Subsector: Value 2003-2008
Table 55 Sales of Eye Care by Subsector: % Value Growth 2003-2008
Table 56 Eye Care Company Shares by Value 2004-2008
Table 57 Eye Care Brand Shares by Value 2005-2008
Table 58 Forecast Sales of Eye Care by Subsector: Value 2008-2013
Table 59 Forecast Sales of Eye Care by Subsector: % Value Growth 2008-2013
WOUND TREATMENTS IN PERU
Headlines
Sector Data
Table 60 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 61 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 62 Wound Treatments Company Shares by Value 2004-2008
Table 63 Wound Treatments Brand Shares by Value 2005-2008
Table 64 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 65 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013
EAR CARE IN PERU
Headlines
Sector Data
Table 66 Sales of Ear Care: Value 2003-2008
Table 67 Sales of Ear Care: % Value Growth 2003-2008
Table 68 Ear Care Company Shares by Value 2004-2008
Table 69 Ear Care Brand Shares by Value 2005-2008
Table 70 Forecast Sales of Ear Care: Value 2008-2013
Table 71 Forecast Sales of Ear Care: % Value Growth 2008-2013
ADULT MOUTH CARE IN PERU
Headlines
Sector Data
Table 72 Sales of Adult Mouth Care: Value 2003-2008
Table 73 Sales of Adult Mouth Care: % Value Growth 2003-2008
Table 74 Adult Mouth Care Company Shares by Value 2004-2008
Table 75 Adult Mouth Care Brand Shares by Value 2005-2008
Table 76 Forecast Sales of Adult Mouth Care: Value 2008-2013
Table 77 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013
CALMING AND SLEEPING PRODUCTS IN PERU
Headlines
EMERGENCY CONTRACEPTION IN PERU
Headlines
OTC OBESITY IN PERU
Headlines
OTC TRIPTANS IN PERU
Headlines
CORPORACION INFARMASA SA
Strategic Direction
Key Facts
Summary 3 Corporación Infarmasa SA: Key Facts
Summary 4 Corporación Infarmasa SA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 5 Corporación Infarmasa SA: Competitive Position 2008
FARMINDUSTRIA SA
Strategic Direction
Key Facts
Summary 6 Farmaindustria SA: Key Facts
Company Background
Production
Competitive Positioning
Summary 7 Farmindustria SA: Competitive Position 2008
MEDIFARMA SA
Strategic Direction
Key Facts
Summary 8 Medifarma SA: Key Facts
Company Background
Production
Competitive Positioning
Summary 9 Medifarma SA: Competitive Position 2008